Esketamine and Perioperative Depressive Symptoms

Clinical trial NCT04425473 · COMPLETED

Trial details

NCT number: NCT04425473
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Depressive Symptoms Esketamine Perioperative Complication Major Surgery

Start date: 2021-02-19
Primary completion: 2024-06-23
Enrollment: 435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.